ebook img

Device-Based Therapy of Cardiac Rhythm Abnormalities - Af-Ablation PDF

44 Pages·2008·0.7 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Device-Based Therapy of Cardiac Rhythm Abnormalities - Af-Ablation

Learn and Live SM ACC/AHA Pocket Guideline Based on the ACC/AHA/HRS 2008 Guidelines Device-Based Therapy of Cardiac Rhythm Abnormalities May 2008 Special thanks to Distributed with the support of an educational grant from Medtronic Inc. Medtronic Inc. was not involved in the development of this publication and in no way influenced its content. Device-Based Therapy of Cardiac Rhythm Abnormalities May 2008 Writing Committee Andrew E. Epsten, MD, FACC, FAHA, FHRS, Char John P. DMarco, MD, PhD, FACC, FAHA, FHRS Kenneth A. Ellenbogen, MD, FACC, FAHA, FHRS N.A. Mark Estes III, MD, FACC, FAHA, FHRS Roger A. Freedman, MD, FACC, FHRS Leonard S. Gettes, MD, FACC, FAHA Gabrel Gregoratos, MD, FACC, FAHA A. Marc Gllnov, MD, FACC, FAHA Stephen C. Hammll, MD, FACC, FHRS Davd L. Hayes, MD, FACC, FAHA, FHRS Mark A. Hlatky, MD, FACC, FAHA L. Krstn Newby, MD, FACC, FAHA Rchard L. Page, MD, FACC, FAHA, FHRS Mark H. Schoenfeld, MD, FACC, FAHA, FHRS Mchael J. Slka, MD, FACC Lynne Warner Stevenson, MD, FACC, FAHA Mchael O. Sweeney, MD, FACC  © 2008 American College of Cardiology Foundation and American Heart Association, Inc. The following material was adapted from the ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. For a copy of the summary article (J Am Coll Cardiol 2008;51: 2085–105; Circulation 2008;117:2820–40) and full report, visit our Web sites at http://www.acc.org or http://www.americanheart.org or call the ACC Resource Center at 1-800-253-4636, ext. 5603. Contents I. Introduction ................................................... 4 II. Recommendations for Permanent Pacing in Sinus Node Dysfunction .......................................13 III. Recommendations for Acquired ..............................15 Atrioventricular Block in Adults IV. Recommendations for Permanent Pacing in Chronic Bifascicular Block .....................................19 V. Recommendations for Permanent Pacing After the Acute Phase of Myocardial Infarction ...................21 VI. Recommendations for Permanent Pacing in Hypersensitive Carotid Sinus Syndrome and Neurocardiogenic Syncope ...........23 VII. Recommendations for Pacing After Cardiac Transplantation ....24 VIII. Recommendations for Permanent Pacemakers That Automatically Detect and Pace to Terminate Tachycardias .........25  IX. Recommendations for Pacing to Prevent Tachycardia ...........26 X. Recommendation for Pacing to Prevent Atrial Fibrillation .......27 XI. Recommendations for Cardiac Resynchronization Therapy in Patients With Severe Systolic Heart Failure .....................27 XII. Recommendations for Pacing in Patients With Hypertrophic Cardiomyopathy ..............................29 XIII. Recommendations for Permanent Pacing in Children, Adolescents, and Patients With Congenital Heart Disease ..........30 XIV. Recommendations for Implantable Cardioverter-Defibrillators ..........................33 XV. Recommendations for Implantable Cardioverter-Defibrillators in Pediatric Patients and Patients With Congenital Heart Disease ......................38  I. Introduction The focus of these gudelnes s the approprate use of heart rhythm devces (pacemakers for bradyarrhythmas and heart falure management, e.g., cardac resynchronzaton, and mplantable cardoverter-defbrllators [ICDs]), not the treatment of cardac arrhythmas. The fact that the use of a devce for treatment of a partcular condton s lsted as a Class I ndcaton (benefcal, useful, and effectve) does not preclude the use of other therapeutc modaltes that may be equally effec- tve. As wth all clncal practce gudelnes, the recommendatons n ths document focus on treatment of an average patent wth a specfc  dsorder and may be modfed by patent comor- bdtes, lmtaton of lfe expectancy because of coexstng dseases, and other stuatons that only the prmary treatng physcan may evaluate approprately. The recommendatons lsted n ths document are, whenever possble, evdence based. The schema for classfcaton of recommendatons and level of evdence s summarzed n Table 1, whch also llustrates how the gradng system provdes an estmate of the sze of the treatment effect and an estmate of the certanty of the treatment effect. The followng represents a subset of recommenda- tons for the mplantaton of antarrhythma devces. We chose to provde only recommendatons n the pocket gude and recommend readers access the full-text and executve summary documents for more explanaton. Table 2 and Figures 1 and 2 are provded to help practtoners choose whch pacng devce s approprate for an ndvdual patent.  Table 1. Applying Classification of Recommendations and Level of Evidence SIzE oF TREATMENT EFFECT CLASS I CLASS IIA Benefit >>> Risk Benefit >> Risk Procedure/Treatment Additional studies with shOuLD be performed/ focused objectives needed administered IT Is ReasOnabLe to per- form procedure/administer treatment t C LeveL A n Recommendation that n Recommendation in favor E f procedure or treatment of treatment or procedure f Multiple populations t E evaluated* is useful/effective being useful/effective En Data derived from multi- n sufficient evidence from n some conflicting evidence M multiple randomized trials from multiple randomized t ple randomized clinical A or meta-analyses trials or meta-analyses E trials or meta-analyses R t f on) o LLiemvieteLd B populations pnr oRceecdoumrem oern tdraetaiotmn ethnat t onf Rtreecaotmmemnet nodra ptrioonc eind ufraev or Si evaluated* is useful/effective being useful/effective ECi Data derived from a n Limited evidence from n some conflicting evidence PR single randomized trial or single randomized trial or from single randomized trial y ( nonrandomized studies nonrandomized studies or nonrandomized studies t n Ai Rt LeveL C n Recommendation that n Recommendation in favor CE Very limited populations procedure or treatment is of treatment or procedure of evaluated* useful/effective being useful/effective tE Only consensus opinion n Only expert opinion, case n Only diverging expert MA of experts, case studies, studies, or standard of care opinion, case studies, ti or standard of care or standard of care S E suggested phrases for should is reasonable writing recommendations† is recommended can be useful/effective/beneficial is indicated is probably recommended is useful/effective/beneficial or indicated 

Description:
grant from Medtronic Inc. Medtronic Inc. was not Page 3 . sentences that express a complete thought .. whom comorb d t es and age d ffer from those n tr al.
See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.